Huaren Pharmaceutical Co., Ltd. (SHE:300110)
China
· Delayed Price · Currency is CNY 3.300
+0.050 (1.54%)
At close: Mar 10, 2026
Huaren Pharmaceutical Revenue
Huaren Pharmaceutical had revenue of 352.37M CNY in the quarter ending September 30, 2025, with 16.62% growth. This brings the company's revenue in the last twelve months to 1.26B, down -15.94% year-over-year. In the year 2024, Huaren Pharmaceutical had annual revenue of 1.35B, down -17.30%.
Revenue (ttm)
1.26B
Revenue Growth
-15.94%
P/S Ratio
3.11
Revenue / Employee
504.14K
Employees
2,491
Market Cap
3.90B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.35B | -283.09M | -17.30% |
| Dec 31, 2023 | 1.64B | 16.76M | 1.04% |
| Jan 1, 2023 | 1.62B | 58.64M | 3.76% |
| Jan 1, 2022 | 1.56B | 244.26M | 18.55% |
| Dec 31, 2020 | 1.32B | -145.35M | -9.94% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Jan 1, 2018 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Tibet AIM Pharm. | 628.02M |
| Harbin Medisan Pharmaceutical | 874.60M |
| Shandong Wohua Pharmaceutical | 816.95M |
| Shanghai MicuRx Pharmaceutical | 141.77M |
| Henan Taloph Pharmaceutical Stock Co.,Ltd | 1.79B |
| Honz Pharmaceutical | 435.39M |
| PKU HealthCare Corp.,Ltd. | 1.76B |
| Tuoxin Pharmaceutical Group | 367.49M |